However, in other studies, DNA damage to the stroma is considered crucial for establishing a chemoresistant bone marrow niche, as it has been shown that such stroma provides resistance to AML cells against adriamycin and idarubicin-mediated killing through FGF10-FGFR2 signaling (37). This evidence concerns the gene FGFR2 and acute myeloid leukemia.